机器人可见光光学相干断层扫描显示节段性施莱姆管解剖及节段性毛果芸香碱反应
研究用机器人可见光光学相干断层扫描(vis-OCT)在小鼠中环周成像房水流出通路,观察施莱姆管(SC)解剖及局部滴用毛果芸香碱后的反应。环周成像显示SC解剖呈节段性,颞侧平均横截面积最大,鼻侧最小(P = 0.018)。滴用1%毛果芸香碱后SC体积增幅大于人工泪液对照组(26.8 ± 5.0% vs 8.9 ± 4.6%,P = 0.030),且该变化亦呈节段性。
要点
- 机器人vis-OCT可无创环周成像小鼠房水流出通路中的施莱姆管。
- SC解剖呈节段性:颞侧平均横截面积最大(3971 ± 328 µm2),鼻侧最小(2727 ± 218 µm2,P = 0.018)。
- 1%毛果芸香碱后SC体积增幅大于对照(26.8 ± 5.0% vs 8.9 ± 4.6%,P = 0.030),以上方和鼻侧节段更明显。
核心结论
- 环周无创成像可在体内完成房水流出通路成像,观察到节段性SC解剖,与已知小梁网房水流出通路的节段性一致;还观察到SC对毒蕈碱激动剂的节段性解剖反应。
- 作者认为,房水流出通路环周存在节段性青光眼药物反应,这一观察可能影响患者对青光眼治疗的反应。
研究设计与样本
- 研究采用机器人可见光光学相干断层扫描(vis-OCT)进行前节成像,以保持激光垂直照射对准SC。
- 共研究16只小鼠,用于重复性测试及局部用药后房水流出(AHO)通路反应研究。
- 给予药用级毛果芸香碱(1%;n = 5)或对照人工泪液(n = 9),在用药前及用药后15分钟进行vis-OCT成像。
- 环周测量SC面积和体积。
主要发现
- 环周vis-OCT提供房水流出通路的高分辨率成像,可显示节段性SC解剖。
- SC平均横截面积颞侧最大(3971 ± 328 µm2),鼻侧最小(2727 ± 218 µm2;P = 0.018)。
- 毛果芸香碱组SC体积增加26.8 ± 5.0%,对照组增加8.9 ± 4.6%(P = 0.030)。
- 毛果芸香碱的改变亦呈节段性:上方体积增加毛果芸香碱组31.6 ± 8.9% vs 对照组1.8 ± 5.7%(P = 0.023);鼻侧毛果芸香碱组41.1 ± 15.3% vs 对照组13.9 ± 4.5%(P = 0.045)。
关键数值与推荐
- SC平均横截面积:颞侧3971 ± 328 µm2,鼻侧2727 ± 218 µm2(P = 0.018)。
- SC体积增加:毛果芸香碱组26.8 ± 5.0% vs 对照组8.9 ± 4.6%(P = 0.030)。
- 上方SC体积增加:毛果芸香碱组31.6 ± 8.9% vs 对照组1.8 ± 5.7%(P = 0.023)。
- 鼻侧SC体积增加:毛果芸香碱组41.1 ± 15.3% vs 对照组13.9 ± 4.5%(P = 0.045)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To use robotic visible-light optical coherence tomography (vis-OCT) to study circumferential segmental Schlemm's canal (SC) anatomy in mice after topical pilocarpine administration. METHODS: Anterior segment imaging using a robotic vis-OCT to maintain perpendicular laser illumination aimed at SC was performed. Sixteen mice were studied for repeatability testing and to study aqueous humor outflow (AHO) pathway response to topical drug. Pharmaceutical-grade pilocarpine (1%; n = 5) or control artificial tears (n = 9) were given, and vis-OCT imaging was performed before and 15 minutes after drug application. SC areas and volumes were measured circumferentially. RESULTS: Circumferential vis-OCT provided high-resolution imaging of the AHO pathways. Segmental SC anatomy was visualized with the average cross-sectional area greatest temporal (3971 ± 328 µm2) and the least nasal (2727 ± 218 µm2; P = 0.018). After pilocarpine administration, the SC became larger (pilocarpine, 26.8 ± 5.0% vs. control, 8.9 ± 4.6% volume increase; P = 0.030). However, the pilocarpine alteration was also segmental, with a greater increase observed superior (pilocarpine, 31.6 ± 8.9% vs. control, 1.8 ± 5.7% volume increase; P = 0.023) and nasal (pilocarpine, 41.1 ± 15.3% vs. control, 13.9 ± 4.5% volume increase; P = 0.045). CONCLUSIONS: Circumferential noninvasive imaging of the AHO pathways was done in vivo. Segmental SC anatomy was seen, consistent with the known segmental nature of trabecular AHO. Segmental SC anatomical response to a muscarinic agonist was also observed. Segmental glaucoma drug response around the circumference of AHO pathways is an observation that may influence patient response to glaucoma treatments.
引用
- Fang R, Zhang P, Kim D, et al. Robotic Visible-Light Optical Coherence Tomography Visualizes Segmental Schlemm's Canal Anatomy and Segmental Pilocarpine Response. Invest Ophthalmol Vis Sci. 2025. PMID: 39964322. doi:10.1167/iovs.66.2.47
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。